Enhancing cellular immune response to HBV M DNA vaccine in mice by codelivery of interleukin-18 recombinant

Journal of Zhejiang University: Science A

Volumn 5, Issue 4, 2004, Pages 467-471

  Chen, Jian zhong ^a   Zhu, Hai hong ^a   Liu, Ke zhou ^a   Chen, Zhi ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

A; DNA vaccines; Hepatitis B virus; Immune response; Interleukin 18; R392

Indexed keywords

DNA; ENCODING (SYMBOLS); GENE ENCODING; IMMUNE SYSTEM; IMMUNIZATION; MAMMALS; SIGNAL ENCODING; VACCINES; VIRUSES;

A; CELLULARS; CO DELIVERIES; DNA VACCINE; HEPATITIS B VIRUS; IMMUNE RESPONSE; INTERLEUKIN-18; PLASMID ENCODING; R392; SPLENOCYTES;

ANTIBODIES;

CYTOKINE; DNA VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; HEPATITIS B VACCINE; INTERLEUKIN 18; MATRIX PROTEIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; IN VITRO STUDY; MOUSE;

ANIMALS; CYTOKINES; HEPATITIS B ANTIBODIES; HEPATITIS B ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; IMMUNITY, CELLULAR; INTERLEUKIN-18; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL MATRIX PROTEINS;

EID: 6044278007     PISSN: 1673565X     EISSN: 18621775     Source Type: Journal    
DOI: 10.1631/jzus.2004.0467     Document Type: Article

References (24)

1. Babiuk, L.A., Babiul, S.L., Baca-Estrada, M.E., 2002. Novel vaccine strategies.Adv Virus Res,58:29–80. DOI: 10.1016/S0065-3527(02)58002-7
2. Beckebaum, S., Cicinnati, V.R., Gerken, G., 2002. DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?Rev Med Virol,12(5):297–319. DOI: 10.1002/rmv.359
3. Biet, F., Locht, C., Kremer, L., 2002. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens.J Mol Med,80(3):147–162. DOI: 10.1007/s00109-001-0307-1
4. Chen, J.Z., Zhu, H.H., Liu, K.Z., Chen, Z., 2002. Immuneresponse induced in mice by codelivery of IL-18 recombinant and HBV S gene DNA vaccine.Chin J Infect Dis,20(3):156–158 (in Chinese).
5. Chisari, F.V., Ferrari, C., 1995. Hepatitis B virus immunopathogenesis.Annu Rev Immunol,13:29–60. DOI: 10.1146/annurev.iy.13.040195.000333
6. Chow, Y.H., Huang, W.L., Chi, W.K., Chu, Y.D., Tao, M.H., 1997. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.J Virol,71(1):169–178. DOI: 10.1128/jvi.71.1.169-178.1997
7. Chow, Y.H., Chiang, B.L., Lee, Y.L., Chi, W.K., Lin, W.C., Chen, Y.T., Tao, M.H., 1998. Development of Th1 and Th2 populations and the nature of immune response to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.J Immunol,160(3):1320–1329. DOI: 10.4049/jimmunol.160.3.1320
8. Davis, H.L., Mancini, M., Michel, M.L., Whalen, R.G., 1996. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.Vaccine,14(9):910–915. DOI: 10.1016/0264-410X(95)00255-Y
9. Franco, A., Guidotti, L.G., Hobbs, M.V., Pasquetto, V., Chisari, F.V., 1997. Pathogenic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice.J Immunol,159(4):2001–2008. DOI: 10.4049/jimmunol.159.4.2001
10. Geissler, M., Tokushige, K., Chante, C.C., Zurawski, V.R. Jr., Wands, J.R., 1997. Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization.Gastroenterology,112(4):1307–1320. DOI: 10.1016/S0016-5085(97)70145-8
11. Geissler, M., Schirmbeck, R., Reimann, J., Blum, H.E., Wands, J.R., 1998. Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle and but not the large hepatitis B virus surface antigen in mice.Hepatology,28(1):202–210. DOI: 10.1002/hep.510280126
12. Guidotti, L.G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., Chisari, F.V., 1999. Viral clearance without destruction of infected cells during acute HBV infection.Science,284(5415):825–829. DOI: 10.1126/science.284.5415.825
13. Jung, M.C., Hartmann, B., Gerlach, J.T., Diepolder, H., Gruber, R., Schraut, W., Gruner, N., Zachoval, R., Hoffmann, R., Santantonio, T., Wachtler, M., Pape, G.R., 1999. Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection.Virology,261(2):165–172. DOI: 10.1006/viro.1999.9833
14. Krieg, A.M., Davis, H.L., 2001. Enhancing vaccines with immune stimulatory CpG DNA.Curr Opin Mol Ther,3(1):15–24.
15. Leroux-Roels, G., Van, Hecke, E., Michielsen, W., Voet, P., Hauser, P., Petre, J., 1994. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.Vaccine,12(9):812–818. DOI: 10.1016/0264-410X(94)90290-9
16. Livingston, B.D., Alexander, J., Crimi, C., Oseroff, C., Celis, E., Daly, K., Guidotti, L.G., Chisari, F.V., Fikes, J., Chesnut, R.W., Sette, A., 1999. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans.J. Immunol,162(5):3088–3095. DOI: 10.4049/jimmunol.162.5.3088
17. Mancini, M., Hadchouel, M., Davis, H.L., Whalen, R.G., Tiollais, P., Michel, M.L., 1996. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state.Proc Natl Acad Sci USA,93(22):12496–12501. DOI: 10.1073/pnas.93.22.12496
18. Nakanishi, K., Yoshimoto, T., Tsutsui, H., Okamura, H., 2001. Interleukin-18 regulates both Th1 and Th2 responses.Annu Rev Immunol,19:423–474. DOI: 10.1146/annurev.immunol.19.1.423
19. Oka, Y., Akbar, S.M., Horrike, N., Joko, K., Onji, M., 2001. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.Immunology,103(1):90–97. DOI: 10.1046/j.1365-2567.2001.01202.x
20. Rehermann, B., Fowler, P., Sidney, J., Person, J., Redeker, A., Brown, M., Moss, B., Sette, A., Chisari, F.V., 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.J Exp Med,181(3):1047–1058. DOI: 10.1084/jem.181.3.1047
21. Rehermann, B., Lau, D., Hoofnagle, J.H., Chisari, F.V., 1996. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.J Clin Invest,97(7):1655–1665. DOI: 10.1172/JCI118592
22. Tang, D.C., DeVit, M., Johnston, S.A., 1992. Genetic immunization is a simple method for cliciting an immune response.Nature,356(6365):152–154. DOI: 10.1038/356152a0
23. Wolff, J.A., Malone, R.W., Williams, P., Chong, W., Acsadi, G., Jani, A., Felgner, P.L., 1990. Direct gene transfer into mouse muscle in vivo.Science,247(4949 Pt 1): 1465–1468. DOI: 10.1126/science.1690918
24. Wolff, J.A., Ludtke, J.J., Acsadi, G., Williams, P., Jani, A., 1992. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle.Hum Mol Genet,1(6):363–369. DOI: 10.1093/hmg/1.6.363